Associated Papers
Heterogeneous responses and resistant mechanisms to crizotinib in ALK-positive advanced non-small cell lung cancer.
Kang J et al.
Thoracic Cancer, 2018
29978950 (PubMed )
Supplement: TCA-9-1093-s006.xlsx › Sheet1
Select a paper to view details